-
2
-
-
0028229508
-
Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM?
-
Taylor S.I., Accili D., Imai Y. Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM?. Diabetes 1994, 43:735-740.
-
(1994)
Diabetes
, vol.43
, pp. 735-740
-
-
Taylor, S.I.1
Accili, D.2
Imai, Y.3
-
3
-
-
34247362354
-
Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies
-
Meece J. Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies. Curr. Med. Res. Opin. 2007, 23:933-944.
-
(2007)
Curr. Med. Res. Opin.
, vol.23
, pp. 933-944
-
-
Meece, J.1
-
4
-
-
77951044560
-
Efficacy and safety of the once-daily human GLP-1 analogue, liraglutide, vs glibenclamide monotherapy in Japanese patients with type 2 diabetes
-
Seino Y., Rasmussen M.F., Nishida T., Kaku K. Efficacy and safety of the once-daily human GLP-1 analogue, liraglutide, vs glibenclamide monotherapy in Japanese patients with type 2 diabetes. Curr. Med. Res. Opin. 2010, 26:1013-1022.
-
(2010)
Curr. Med. Res. Opin.
, vol.26
, pp. 1013-1022
-
-
Seino, Y.1
Rasmussen, M.F.2
Nishida, T.3
Kaku, K.4
-
5
-
-
75549091061
-
Incretin-based therapies: viewpoints on the way to consensus
-
Nauck M.A., Vilsbøll T., Gallwitz B., Garber A., Madsbad S. Incretin-based therapies: viewpoints on the way to consensus. Diabetes Care 2009, 32 Suppl 2:S223-S231.
-
(2009)
Diabetes Care
-
-
Nauck, M.A.1
Vilsbøll, T.2
Gallwitz, B.3
Garber, A.4
Madsbad, S.5
-
6
-
-
58149265313
-
Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes
-
Ahrén B. Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes. Expert. Opin. Emerg. Drugs 2008, 13:593-607.
-
(2008)
Expert. Opin. Emerg. Drugs
, vol.13
, pp. 593-607
-
-
Ahrén, B.1
-
7
-
-
58149347643
-
DPP4 inhibitors: a new approach in diabetes treatment
-
Doupis J., Veves A. DPP4 inhibitors: a new approach in diabetes treatment. Adv. Ther. 2008, 25:627-643.
-
(2008)
Adv. Ther.
, vol.25
, pp. 627-643
-
-
Doupis, J.1
Veves, A.2
-
8
-
-
53749085064
-
Incretin-based therapies in type 2 diabetes mellitus
-
Chia C.W., Egan J.M. Incretin-based therapies in type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 2008, 93:3703-3716.
-
(2008)
J. Clin. Endocrinol. Metab.
, vol.93
, pp. 3703-3716
-
-
Chia, C.W.1
Egan, J.M.2
-
9
-
-
10644275303
-
Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor
-
Soga T., Ohishi T., Matsui T., Saito T., Matsumoto M., Takasaki J., Matsumoto S., Kamohara M., Hiyama H., Yoshida S., Momose K., Ueda Y., Matsushime H., Kobori M., Furuichi K. Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. Biochem. Biophys. Res. Commun. 2005, 28:744-751.
-
(2005)
Biochem. Biophys. Res. Commun.
, vol.28
, pp. 744-751
-
-
Soga, T.1
Ohishi, T.2
Matsui, T.3
Saito, T.4
Matsumoto, M.5
Takasaki, J.6
Matsumoto, S.7
Kamohara, M.8
Hiyama, H.9
Yoshida, S.10
Momose, K.11
Ueda, Y.12
Matsushime, H.13
Kobori, M.14
Furuichi, K.15
-
10
-
-
33750520737
-
Expression and distribution of Gpr119 in the pancreatic islets of mice and rats: predominant localization in pancreatic polypeptide-secreting PP-cells
-
Sakamoto Y., Inoue H., Kawakami S., Miyawaki K., Miyamoto T., Mizuta K., Itakura M. Expression and distribution of Gpr119 in the pancreatic islets of mice and rats: predominant localization in pancreatic polypeptide-secreting PP-cells. Biochem. Biophys. Res. Commun. 2006, 351:474-480.
-
(2006)
Biochem. Biophys. Res. Commun.
, vol.351
, pp. 474-480
-
-
Sakamoto, Y.1
Inoue, H.2
Kawakami, S.3
Miyawaki, K.4
Miyamoto, T.5
Mizuta, K.6
Itakura, M.7
-
11
-
-
33644627958
-
Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents
-
Overton H.A., Babbs A.J., Doel S.M., Fyfe M.C., Gardner L.S., Griffin G., Jackson H.C., Procter M.J., Rasamison C.M., Tang-Christensen M., Widdowson P.S., Williams G.M., Reynet C. Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell. Metab. 2006, 3:167-175.
-
(2006)
Cell. Metab.
, vol.3
, pp. 167-175
-
-
Overton, H.A.1
Babbs, A.J.2
Doel, S.M.3
Fyfe, M.C.4
Gardner, L.S.5
Griffin, G.6
Jackson, H.C.7
Procter, M.J.8
Rasamison, C.M.9
Tang-Christensen, M.10
Widdowson, P.S.11
Williams, G.M.12
Reynet, C.13
-
12
-
-
34248527678
-
A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release
-
Chu Z.L., Jones R.M., He H., et al. A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release. Endocrinology 2007, 148:2601-2609.
-
(2007)
Endocrinology
, vol.148
, pp. 2601-2609
-
-
Chu, Z.L.1
Jones, R.M.2
He, H.3
-
13
-
-
42449126696
-
A role for intestinal endocrine cell-expressed GPR119 in glycemic control by enhancing GLP-1 and GIP release
-
Chu Z.L., Jones R.M., He H., Carroll C., Gutierrez V., Lucman A., Moloney M., Gao H., Mondala H., Bagnol D., Unett D., Liang Y., Demarest K., Semple G., Behan D.P., Leonard J. A role for intestinal endocrine cell-expressed GPR119 in glycemic control by enhancing GLP-1 and GIP release. Endocrinology 2008, 149:2038-2047.
-
(2008)
Endocrinology
, vol.149
, pp. 2038-2047
-
-
Chu, Z.L.1
Jones, R.M.2
He, H.3
Carroll, C.4
Gutierrez, V.5
Lucman, A.6
Moloney, M.7
Gao, H.8
Mondala, H.9
Bagnol, D.10
Unett, D.11
Liang, Y.12
Demarest, K.13
Semple, G.14
Behan, D.P.15
Leonard, J.16
-
14
-
-
70349770172
-
GPR119 agonists for the treatment of type 2 diabetes
-
Jones R.M., Leonard J.N., Buzard D.J., Lehmann J. GPR119 agonists for the treatment of type 2 diabetes. Expert. Opin. Ther. Pat. 2009, 19:1339-1359.
-
(2009)
Expert. Opin. Ther. Pat.
, vol.19
, pp. 1339-1359
-
-
Jones, R.M.1
Leonard, J.N.2
Buzard, D.J.3
Lehmann, J.4
-
15
-
-
77956936188
-
Identification of a novel GPR119 agonist, AS1269574, With in vitro and in vivo glucose-stimulated insulin secretion
-
Yoshida S., Ohishi T., Matsui T., Shibasaki M. Identification of a novel GPR119 agonist, AS1269574, With in vitro and in vivo glucose-stimulated insulin secretion. Biochem. Biophys. Res. Commun. 2010, 400:437-441.
-
(2010)
Biochem. Biophys. Res. Commun.
, vol.400
, pp. 437-441
-
-
Yoshida, S.1
Ohishi, T.2
Matsui, T.3
Shibasaki, M.4
-
16
-
-
0025613755
-
Isolation of pancreatic islets and primary culture of the intact microorgans or of dispersed islet cells
-
Wollheim C.B., Meda P., Halban P.A. Isolation of pancreatic islets and primary culture of the intact microorgans or of dispersed islet cells. Methods Enzymol. 1990, 192:188-223.
-
(1990)
Methods Enzymol.
, vol.192
, pp. 188-223
-
-
Wollheim, C.B.1
Meda, P.2
Halban, P.A.3
-
17
-
-
33644932611
-
Postprandial glucose regulation: new data and new implications
-
Leiter L.A., Ceriello A., Davidson J.A., Hanefeld M., Monnier L., Owens D.R., Tajima N., Tuomilehto J. Postprandial glucose regulation: new data and new implications. Clin. Ther. 2005, 27 Suppl B:S42-S56.
-
(2005)
Clin. Ther.
, vol.27
, Issue.SUPPL B
-
-
Leiter, L.A.1
Ceriello, A.2
Davidson, J.A.3
Hanefeld, M.4
Monnier, L.5
Owens, D.R.6
Tajima, N.7
Tuomilehto, J.8
-
18
-
-
34247636085
-
Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels
-
Woerle H.J., Neumann C., Zschau S., Tenner S., Irsigler A., Schirra J., Gerich J.E., Göke B. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels. Diabetes Res. Clin. Pract. 2007, 77:280-285.
-
(2007)
Diabetes Res. Clin. Pract.
, vol.77
, pp. 280-285
-
-
Woerle, H.J.1
Neumann, C.2
Zschau, S.3
Tenner, S.4
Irsigler, A.5
Schirra, J.6
Gerich, J.E.7
Göke, B.8
-
19
-
-
67349176115
-
Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes
-
Ahrén B. Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat. Rev. Drug. Discov. 2009, 8:369-385.
-
(2009)
Nat. Rev. Drug. Discov.
, vol.8
, pp. 369-385
-
-
Ahrén, B.1
-
20
-
-
36148996843
-
G-protein-coupled receptors and islet function-implications for treatment of type 2 diabetes
-
Winzell M.S., Ahrén B. G-protein-coupled receptors and islet function-implications for treatment of type 2 diabetes. Pharmacol. Ther. 2007, 116:437-448.
-
(2007)
Pharmacol. Ther.
, vol.116
, pp. 437-448
-
-
Winzell, M.S.1
Ahrén, B.2
-
21
-
-
70349988797
-
G-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta-cell
-
Morgan N.G., Dhayal S. G-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta-cell. Biochem. Pharmacol. 2009, 78:1419-1427.
-
(2009)
Biochem. Pharmacol.
, vol.78
, pp. 1419-1427
-
-
Morgan, N.G.1
Dhayal, S.2
-
22
-
-
67649979936
-
GPR119 agonists: a promising new approach for the treatment of type 2 diabetes and related metabolic disorders
-
Shah U. GPR119 agonists: a promising new approach for the treatment of type 2 diabetes and related metabolic disorders. Curr. Opin. Drug Discov. Dev. 2009, 12:519-532.
-
(2009)
Curr. Opin. Drug Discov. Dev.
, vol.12
, pp. 519-532
-
-
Shah, U.1
|